- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Nausea and vomiting
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 890KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 45KB)
Fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) – July 2020
Fosnetupitant (as chloride hydrochloride)/ palonosetron (as hydrochloride): Powder for Injection containing fosnetupitant 235 mg and palonosetron 250 mg; Akynzeo IV®
Last updated
30 October 2020